IL33 and urinary bladder neoplasm: We first confirmed the high expression of ST2 by bladder ILC2s compared to ILC1s and 3, which remained stable along the bladder tumor growth (Supplementary Figure 3C), consistent with previous observations (38) and suggesting that bladder ILC2s may be responsive to IL-33.